National Bank of Canada
ONC

National Bank of Canada’s BeOne Medicines Ltd ONC Stock Holding History

National Bank of Canada’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5
Closed -$1.68K – 3199
2025
Q3 		$1.68K Sell
5
-60,549
-100% -$18.4M ﹤0.01% 2607
2025
Q2 		$14.7M Buy
60,554
+26,654
+79% +$6.54M 0.01% 655
2025
Q1 		$9.23M Buy
+33,900
New +$7.93M 0.01% 736
2024
Q3 		– Sell
-52
Closed -$7.53K – 3084
2024
Q2 		$7.53K Hold
52
– – ﹤0.01% 2189
2024
Q1 		$8.37K Buy
52
+19
+58% +$3.06K ﹤0.01% 2207
2023
Q4 		$5.84K Hold
33
– – ﹤0.01% 2269
2023
Q3 		$5.89K Sell
33
-32,197
-100% -$6.37M ﹤0.01% 2319
2023
Q2 		$5.83M Buy
32,230
+32,200
+107,333% +$7.42M 0.01% 677
2023
Q1 		$6.47K Hold
30
– – ﹤0.01% 2239
2022
Q4 		$6.6K Sell
30
-3
-9% -$550 ﹤0.01% 2270
2022
Q3 		$4K Sell
33
-7
-18% -$1.2K ﹤0.01% 2409
2022
Q2 		$6K Buy
40
+29
+264% +$4.53K ﹤0.01% 2402
2022
Q1 		$2K Buy
11
+8
+267% +$1.7K ﹤0.01% 2733
2021
Q4 		$1K Buy
+3
New +$1.01K ﹤0.01% 2778

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

National Bank of Canada's ONC Position: Q4 2025 in Review

National Bank of Canada sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 5 shares — an estimated $1.68K sold.

National Bank of Canada first reported a position in ONC in Q4 2021 and held it in 14 quarters. The position peaked at $14.7M in Q2 2025. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • National Bank of Canada reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • National Bank of Canada sold 5 BeOne Medicines Ltd shares in Q4 2025, an estimated $1.68K.
  • National Bank of Canada first reported a position in BeOne Medicines Ltd in Q4 2021 and held it in 14 quarters.
  • National Bank of Canada's BeOne Medicines Ltd position peaked at $14.7M in Q2 2025.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.